← FDA Drug Approvals (Drugs@FDA)

TIVDAK

BLA · Biologics License Application · Sponsor: SEAGEN · Approved 2021-09-20

Drug application

FDA Application #

BLA761208

Application type

Biologics License Application

Brand name

TIVDAK

Generic name

TISOTUMAB VEDOTIN

Active ingredients

TISOTUMAB VEDOTIN-TFTV

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SEAGEN

Manufacturer

SEAGEN INC.

First approval

2021-09-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown